Takako Oka
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Anti-programmed Death-ligand 1 Antibody-associated Eosinophilic Granulomatosis with Polyangiitis in Non-small Cell Lung Cancer.
Journal: Internal medicine (Tokyo, Japan)
Published: December 24, 2025
Management of Advanced Lung Cancer in Pregnancy: Multidisciplinary Treatment and Early Delivery.
Journal: Internal medicine (Tokyo, Japan)
Published: June 04, 2025
Pseudoprogression of pleural effusion in lung cancer treated with immunotherapy: a case report.
Journal: Translational lung cancer research
Published: April 07, 2025
Association between pleurodesis before immunotherapy and pneumonitis in non-small cell lung cancer.
Journal: Respiratory investigation
Published: April 04, 2025
Potassium-competitive acid blocker has more negative impacts on clinical outcomes in patients with non-small cell lung cancer treated with checkpoint inhibitors than those of proton pump inhibitors.
Journal: International journal of clinical oncology
Published: February 03, 2025
Efficacy of ramucirumab combined with erlotinib or osimertinib in untreated EGFR-mutated NSCLC patients with asymptomatic brain metastases: insights from molecular biomarkers in the RELAY-brain trial.
Journal: Investigational new drugs
Published: October 03, 2024
The Macroscopic Appearance of Computed Tomography-guided Needle Biopsy Specimens Correlates with Tumor Metastasis in Non-small Cell Lung Cancer.
Journal: Osaka city medical journal
Published: March 22, 2016
Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR.
Journal: Expert opinion on pharmacotherapy
Published: January 20, 2016
Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 06, 2015
Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study.
Journal: BMC pharmacology & toxicology
Published: April 26, 2014
Reaction of plasma adiponectin level in non-small cell lung cancer patients treated with EGFR-TKIs.
Journal: Osaka city medical journal
Published: August 06, 2013
C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin.
Journal: Clinical Medicine Insights. Oncology
Published: March 08, 2013
Last Updated: 09/26/2026